Citations

Bacterial Toxin Research Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

4945 total record number 317 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 14 out of 34
336 citations found

Anthrax Vaccine Precipitated induces Edema Toxin-neutralizing, Edema Factor-specific antibodies in human recipients

Dumas, EK;Gross, T;Larabee, J;Pate, L;Cuthbertson, H;Charlton, S;Hallis, B;Engler, RJM;Collins, LC;Spooner, CE;Chen, H;Ballard, J;James, JA;Farris, AD;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Product: Anthrax Lethal Factor (LF-A), Recombinant from B. anthracis Native Sequence

  • Materials and Methods

    Anthrax lethal factor (Product #169), and the chicken IgY polyclonal anti-LF antibody (Product # 769A) are products
    of List Biological Laboratories, Inc.
    The C8 Starwell Maxi Nunc-Immuno Module Plates (cat# 441653) used for LF
    antibody coating and the dimethyl sulfoxide (DMSO) (cat # TS-20684) were purchased from ThermoScientific. The
    96-well, black, flat bottom, non binding plates used for the fluorescent plate assay were from Corning (cat # 3991).
    Bovine plasma (cat # 7310806) was purchased from Lampire Biological Laboratories.

    Sample Preparation: Stock solutions of the fluorogenic substrate, MAPKKide® Plus, were 1.25 mM in DMSO
    based on the peptide content determined by elemental analysis. The substrate was diluted in assay buffer:
    20 mM HEPES, pH 8.0 containing 0.1% Tween-20. For the microplate assays, the LF was dissolved in neat bovine
    plasma and diluted 1:10 in assay buffer. For the HPLC assays, the LF was added to neat bovine plasma and not
    diluted.

    LF Activity Assays:

    Microplate reader: Assays were performed on a SPECTRAmax GEMINI XS fluorescence microplate reader
    (Molecular Devices). The cleavage reaction was initiated by addition of the substrate, MAPKKide® Plus. The
    concentration was optimized to minimize background fluorescence while maintaining measureable cleavage. For
    all experiments the time-dependent increase in fluorescence was monitored at 37°C hourly for 5 or 6 hours followed
    by an additional 18 to 18.5 hr overnight incubation at ambient temperature. The excitation wavelength was set to
    368 nm and emission to 452 nm with a cutoff filter at 435 nm.

    HPLC: The C8 Starwell Maxi Nunc-Immuno Module Plates were coated with 150 μl of a 10 μg/ml solution of
    a chicken affinity purified polyclonal IgY antibody to anthrax lethal factor (List Prod # 769A). Plates were incubated
    with the IgY overnight at 2-8°C and washed three times with 0.1M Glycine-HCl, pH 2.5. This wash was included to
    liberate residual LF retained after the affinity purification of the antibody and was necessary to minimize the background. After 6 washes with PBS containing 0.05% TWEEN-20 (PBST), the anti-LF coated wells were exposed to
    300 μl of a series of LF concentrations in neat plasma. The plates were incubated at 22°C for 2 hours. Plates were
    then washed 6 times with PBST and 250 μl of 1.25 μM MAPKKide® Plus was added. The reaction was allowed to
    proceed for 2, 3.5, and 5 hours at 37°C and overnight at ambient temperature. At each time point 200 μl of the
    reaction mixture was removed from replicate wells and placed in HPLC sample vials.

    HPLC was performed using a Zorbax Eclipse Plus C18 reverse phase column, 4.6 x 150 mm (Agilent) and a guard
    column containing the same resin in a Varian ProStar HPLC system (Agilent). Solvent A was 0.1% TFA in water and
    solvent B was 0.1% TFA in acetonitrile. The 16 minute HPLC method was as follows: 25% B for 0.75 minutes;
    25 to 45% B in 4.75 minutes; 45 to 100% B in 0.75 minutes; 100% B for 3.75 minutes; 100 to 25%B in 0.67 minutes
    and 5.34 minute equilibration with 25% B. The column effluent was monitored using an Hitachi fluorescence detector
    with excitation set to 350 nm and emission at 450 nm to detect the free coumarin fluorophore cleaved from
    MAPKKide® Plus. The injection volume was 20 µl. The 7-amido-4-methylcoumarin (AMC) peak retention time
    was 4.8 minutes.

    Product #169L – Anthrax Lethal Factor (LF-A), Recombinant from B. anthracis Native Sequence
    Product #769B – Anti-Lethal Factor from B. anthracis (Chicken lgY)
    Product #532 – MAPKKide® Plus (AMC) Specific Substrate for Anthrax Lethal Factor

Product: Anthrax Lethal Factor (LF-A), Recombinant from B. anthracis Native Sequence

  • Materials and Methods

    Anthrax lethal factor (Product #169), and the chicken IgY polyclonal anti-LF antibody (Product # 769A) are products
    of List Biological Laboratories, Inc.
    The C8 Starwell Maxi Nunc-Immuno Module Plates (cat# 441653) used for LF
    antibody coating and the dimethyl sulfoxide (DMSO) (cat # TS-20684) were purchased from ThermoScientific. The
    96-well, black, flat bottom, non binding plates used for the fluorescent plate assay were from Corning (cat # 3991).
    Bovine plasma (cat # 7310806) and sheep plasma (cat# 7319006) were purchased from Lampire Biological
    Laboratories. The milk (2% Lucerne) came from the local market.

    Sample Preparation: Stock solutions of the fluorogenic substrate, MAPKKide® Plus, were 1.25 mM in DMSO
    based on the peptide content determined by elemental analysis. The substrate was diluted in assay buffer:
    20 mM HEPES, pH 8.0 containing 0.1% Tween-20. For the microplate assays, the LF was dissolved in neat bovine
    plasma and diluted 1:10 in assay buffer. For the HPLC assays, the LF was added to neat bovine, sheep plasma or
    2% milk without dilution.

    LF Activity Assays:
    Microplate reader: Assays were performed on a SPECTRAmax GEMINI XS fluorescence microplate reader
    (Molecular Devices). The cleavage reaction was initiated by addition of the substrate, MAPKKide® Plus. The
    concentration was optimized to minimize background fluorescence while maintaining measureable cleavage. For
    all experiments the time-dependent increase in fluorescence was monitored at 37°C hourly for 5 or 6 hours followed
    by an additional 18 to 18.5 hr overnight incubation at ambient temperature. The excitation wavelength was set to
    368 nm and emission to 452 nm with a cutoff filter at 435 nm.

    HPLC: The C8 Starwell Maxi Nunc-Immuno Module Plates were coated with 150 μl of a 10 μg/ml solution of
    a chicken affinity purified polyclonal IgY antibody to anthrax lethal factor (List Prod # 769A). Plates were incubated
    with the IgY overnight at 2-8°C and washed three times with 0.1M Glycine-HCl, pH 2.5. This wash was included to
    liberate residual LF retained after the affinity purification of the antibody and was necessary to minimize the background. After 6 washes with PBS containing 0.05% TWEEN-20 (PBST), the anti-LF coated wells were exposed to
    300 μl of a series of LF concentrations in neat plasma. The plates were incubated at 22°C for 2 hours. Plates were
    then washed 6 times with PBST and 250 μl of 1.25 μM MAPKKide® Plus was added. The reaction was allowed to
    proceed for 2, 3.5, and 5 hours at 37°C and overnight at ambient temperature. At each time point 200 μl of the
    reaction mixture was removed from replicate wells and placed in HPLC sample vials.

    HPLC was performed using a Zorbax Eclipse Plus C18 reverse phase column, 4.6 x 150 mm (Agilent) and a guard
    column containing the same resin in a Varian ProStar HPLC system (Agilent). Solvent A was 0.1% TFA in water and
    solvent B was 0.1% TFA in acetonitrile. The 16 minute HPLC method was as follows: 25% B for 0.75 minutes;
    25 to 45% B in 4.75 minutes; 45 to 100% B in 0.75 minutes; 100% B for 3.75 minutes; 100 to 25%B in 0.67 minutes
    and 5.34 minute equilibration with 25% B. The column effluent was monitored using an Hitachi fluorescence detector
    with excitation set to 350 nm and emission at 450 nm to detect the free fluorophore cleaved from MAPKKide® Plus.
    The injection volume was 20 µl. The 7-amido-4-methylcoumarin (AMC) peak retention time was 4.8 minutes.

    Product #169L – Anthrax Lethal Factor (LF-A), Recombinant from B. anthracis Native Sequence
    Product #769B – Anti-Lethal Factor from B. anthracis (Chicken lgY)
    Product #532 – MAPKKide® Plus (AMC) Specific Substrate for Anthrax Lethal Factor

CAN WE ACHIEVE EFFECTIVE ORAL DELIVERY OF VACCINES? EVALUATING A NEW MICROSPHERE BASED CONTROLLED-RELEASE DELIVERY SYSTEM

Mohanraj, SM;Kende, M;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Protection of farm goats by combinations of recombinant peptides and formalin inactivated spores from a lethal Bacillus anthracis challenge under field conditions

Koehler, SM;Buyuk, F;Celebi, O;Demiraslan, H;Doganay, M;Sahin, M;Moehring, J;Ndumnego, OC;Otlu, S;van Heerden, H;Beyer, W;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Combination of poly I:C and Pam3CSK4 enhances activation of B cells in vitro and boosts antibody responses to protein vaccines in vivo

Weir, GM;Karkada, M;Hoskin, D;Stanford, MM;MacDonald, L;Mansour, M;Liwski, RS;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Protection against inhalation anthrax by immunization with Salmonella enterica serovar Typhi Ty21a stably producing protective antigen of Bacillus anthracis

Sim, BK;Li, M;Osorio, M;Wu, Y;Wai, TT;Peterson, JW;James, ER;Chakravarty, S;Gao, L;Xu, R;KC, N;Stafford, RE;Lawrence, WS;Yeager, LA;Peel, JE;Sivasubramani, SK;Chopra, AK;Hoffman, SF;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Lethal factor antibodies contribute to lethal toxin neutralization in recipients of anthrax vaccine precipitated

Dumas, EK;Garman, L;Cuthbertson, H;Charlton, S;Hallis, B;Engler, RJM;Choudhari, S;Picking, WD;James, JA;Farris, AD;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

The PYRIN domain-only protein POP2 inhibits inflammasome priming and activation

Ratsimandresy, RA;Chu, LH;Khare, S;de Almeida, L;Gangopadhyay, A;Indramohan, M;Misharin, AV;Greaves, DR;Perlman, H;Dorfleutner, A;Stehlik, C;

Product: Anthrax Lethal Factor (LF), Recombinant from B. anthracis

Quantitative analysis of the CD4+ T cell response to therapeutic antibodies in healthy donors using a novel T cell:PBMC assay

Schultz, HS;Reedtz-Runge, SL;Bckstrm, BT;Lamberth, K;Pedersen, CR;Kvarnhammar, AM;, ;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis